- About
- Events
- Resource Center
Archives
Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
About This Event
Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
Major depressive disorder affects more than 260 million people worldwide.1 The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%.2 This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
1. World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1
2. Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.
Laury’s Restaurant
350 MacCorkle Ave SE
Charleston, West Virginia United States + Google Map(304) 343-0055 View Venue Website
Jessica Kanai, PharmD
Nephrology Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Jessica Kanai PharmD, is a Nephrology Medical Science Liaison at Otsuka. Dr Kanai obtained her PharmD from Duquesne University in Pittsburgh, Pennsylvania. She completed her PGY-1 residency at Memorial Health University Medical Center in Savannah, Georgia where she stayed on and worked in both emergency medicine and internal medicine. She was responsible for a diverse patient population including those with end stage renal disease. Dr Kanai then went on to obtain her Australian pharmacy license and worked with numerous specialty services at the Royal Hobart Hospital such as neurosurgery, cardiology and pulmonology. Upon returning to the states, she became the nephrology pharmacist at WVU Medicine and was also involved in initiating pharmacy rounding services with WVU Medicine’s cardiology specialty. Dr Kanai is currently a licensed pharmacist in Pennsylvania and West Virginia.
Lisa Voigt, PharmD, BCPS, BCCCP, FASHP
Nephrology Senior Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Lisa Voigt is a PharmD who works as a Medical Science Liaison in Nephrology with Otsuka Pharmaceutical Development & Commercialization, Inc. Prior to joining Otsuka in 2019, Dr Voigt practiced as a Medical Intensive Care Unit and Surgical Intensive Care Unit Pharmacist for 15 years at a tertiary medical center in Buffalo, NY. She earned her Bachelor of Science degree in Pharmaceutics and PharmD from the SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences. She completed a Post-Graduate year 1 Pharmacy Residency and Post-Graduate year 2 Critical Care/Emergency Medicine Pharmacy Residency at the University of Rochester Medical Center in Rochester, NY. Dr Voigt is a Past-President of the New York State Council of Health-system Pharmacists and has served on the Board of Directors for the past 10 years. She is also Past-President of the Western New York Society of Health-system Pharmacists. She is an Adjunct Assistant Professor at SUNY Buffalo, School of Pharmacy and Pharmaceutical Sciences. Dr Voigt holds board certifications in pharmacotherapy as well as critical care pharmacotherapy.
*Drs Kanai and Voigt are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Registration
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - Events
